Found: 5
Select item for more details and to access through your institution.
MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 6, p. 983, doi. 10.1007/s00262-019-02341-9
- By:
- Publication type:
- Article
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1767, doi. 10.3390/cancers16091767
- By:
- Publication type:
- Article
Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092294
- By:
- Publication type:
- Article
Loss of p14 diminishes immunogenicity in melanoma via non‐canonical Wnt signaling by reducing the peptide surface density.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2449, doi. 10.1002/1878-0261.13660
- By:
- Publication type:
- Article
Loss of p14 diminishes immunogenicity in melanoma via non‐canonical Wnt signaling by reducing the peptide surface density.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2449, doi. 10.1002/1878-0261.13660
- By:
- Publication type:
- Article